Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002895 (
sickle cell disease
)
11,747
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Deoxy-hemoglobin S polymerization into rigid fibers is the direct cause of the clinical sequelae observed in
sickle cell disease
(
SCD
). The rate of polymerization of sickle hemoglobin is determined primarily by intracellular hemoglobin concentration, itself dependent on the amount of sickle hemoglobin and on red blood cell (RBC) volume. Dense, dehydrated RBC (DRBC) are observed in
SCD
patients, and their number correlates with hemolytic parameters and complications such as renal dysfunction, leg ulcers and priapism. To identify new genes involved in RBC hydration in
SCD
, we performed the first genome-wide association study for DRBC in 374
sickle cell anemia
(HbSS) patients. We did not find genome-wide significant results, indicating that variants that modulate DRBC have modest-to-weak effects. A secondary analysis demonstrated a nominal association (P=0.003) between DRBC in
SCD
patients and a variant associated with mean corpuscular hemoglobin concentration (MCHC) in non-anemic individuals. This intronic variant controls the expression of
ATP2B4
, the main calcium pump in erythrocytes. Our study highlights
ATP2B4
as a promising target for modulation of RBC hydration in
SCD
patients.
...
PMID:Genome-wide association study of erythrocyte density in sickle cell disease patients. 2855 77